Cargando…
Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders
BACKGROUND: Community advisory structures such as Community Advisory Boards (CABs) play an important role of helping researchers to better understand the community at each phase of the clinical trial. CABs can be a source of accurate information on the community, its perception of proposed research...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899660/ https://www.ncbi.nlm.nih.gov/pubmed/36740683 http://dx.doi.org/10.1186/s12913-023-09136-w |
_version_ | 1784882681619677184 |
---|---|
author | Mijumbi, Andrew Ojok Mugenyi, Levicatus Nanfuka, Mastula Agaba, Collins Ochieng, Joseph |
author_facet | Mijumbi, Andrew Ojok Mugenyi, Levicatus Nanfuka, Mastula Agaba, Collins Ochieng, Joseph |
author_sort | Mijumbi, Andrew Ojok |
collection | PubMed |
description | BACKGROUND: Community advisory structures such as Community Advisory Boards (CABs) play an important role of helping researchers to better understand the community at each phase of the clinical trial. CABs can be a source of accurate information on the community, its perception of proposed research and may identify factors that make community members vulnerable to the problem under investigation. Although CABs help to build mutually beneficial relationships between the researcher(s) and the communities in which the clinical trial is being implemented, effective engagement would require ethical guidance and regulatory oversight. The study assessed the stakeholders’ perspectives regarding the regulatory oversight of CABs in Uganda. METHODS: This was an exploratory study employing qualitative methods of data collection and analysis. Key informant interviews (KIIs) with the trial investigators, CAB chairpersons, community liaison officers, regulators and Research Ethics Committee (REC) chairpersons were conducted. A KII guide was designed and utilized during key informant interviews. The guide included questions on role of investigators and CAB members in clinical trials; challenges of community engagement; facilitation of CABs; regulatory oversight of CABs; work relationships between investigators and CABs; and opinions on how community trials should be conducted among others. All interviews were conducted in English. Qualitative data were transcribed verbatim. A code book was generated based on the transcripts and study objectives. Thematic analysis was used to analyze data and identify themes. Atlas ti was used to support data analysis. RESULTS: Of the 34 respondents, 35.3% were investigators, 32.3% CAB chairpersons, 23.5% research regulators/REC Chairs and 8.8% community liaison officers. The findings of the study revealed that CABs are appointed by the research institution/researcher, operate under the guidance of the researcher with limited independence. Additionally, the CABs provide voluntary service and lack guidelines or regulatory oversight. Four themes emerged. CONCLUSION: The operations and activities of CABs are not regulated by the national regulators or RECs. The regulatory oversight of CABs should be based on contextualized ethical guidelines. Need for additional training in research ethics, community engagement and sensitization on available ethics guidelines for research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-09136-w. |
format | Online Article Text |
id | pubmed-9899660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98996602023-02-06 Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders Mijumbi, Andrew Ojok Mugenyi, Levicatus Nanfuka, Mastula Agaba, Collins Ochieng, Joseph BMC Health Serv Res Research Article BACKGROUND: Community advisory structures such as Community Advisory Boards (CABs) play an important role of helping researchers to better understand the community at each phase of the clinical trial. CABs can be a source of accurate information on the community, its perception of proposed research and may identify factors that make community members vulnerable to the problem under investigation. Although CABs help to build mutually beneficial relationships between the researcher(s) and the communities in which the clinical trial is being implemented, effective engagement would require ethical guidance and regulatory oversight. The study assessed the stakeholders’ perspectives regarding the regulatory oversight of CABs in Uganda. METHODS: This was an exploratory study employing qualitative methods of data collection and analysis. Key informant interviews (KIIs) with the trial investigators, CAB chairpersons, community liaison officers, regulators and Research Ethics Committee (REC) chairpersons were conducted. A KII guide was designed and utilized during key informant interviews. The guide included questions on role of investigators and CAB members in clinical trials; challenges of community engagement; facilitation of CABs; regulatory oversight of CABs; work relationships between investigators and CABs; and opinions on how community trials should be conducted among others. All interviews were conducted in English. Qualitative data were transcribed verbatim. A code book was generated based on the transcripts and study objectives. Thematic analysis was used to analyze data and identify themes. Atlas ti was used to support data analysis. RESULTS: Of the 34 respondents, 35.3% were investigators, 32.3% CAB chairpersons, 23.5% research regulators/REC Chairs and 8.8% community liaison officers. The findings of the study revealed that CABs are appointed by the research institution/researcher, operate under the guidance of the researcher with limited independence. Additionally, the CABs provide voluntary service and lack guidelines or regulatory oversight. Four themes emerged. CONCLUSION: The operations and activities of CABs are not regulated by the national regulators or RECs. The regulatory oversight of CABs should be based on contextualized ethical guidelines. Need for additional training in research ethics, community engagement and sensitization on available ethics guidelines for research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-09136-w. BioMed Central 2023-02-06 /pmc/articles/PMC9899660/ /pubmed/36740683 http://dx.doi.org/10.1186/s12913-023-09136-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Mijumbi, Andrew Ojok Mugenyi, Levicatus Nanfuka, Mastula Agaba, Collins Ochieng, Joseph Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title | Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title_full | Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title_fullStr | Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title_full_unstemmed | Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title_short | Regulation of community advisory boards during conduct of clinical trials in Uganda: a qualitative study involving stakeholders |
title_sort | regulation of community advisory boards during conduct of clinical trials in uganda: a qualitative study involving stakeholders |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899660/ https://www.ncbi.nlm.nih.gov/pubmed/36740683 http://dx.doi.org/10.1186/s12913-023-09136-w |
work_keys_str_mv | AT mijumbiandrewojok regulationofcommunityadvisoryboardsduringconductofclinicaltrialsinugandaaqualitativestudyinvolvingstakeholders AT mugenyilevicatus regulationofcommunityadvisoryboardsduringconductofclinicaltrialsinugandaaqualitativestudyinvolvingstakeholders AT nanfukamastula regulationofcommunityadvisoryboardsduringconductofclinicaltrialsinugandaaqualitativestudyinvolvingstakeholders AT agabacollins regulationofcommunityadvisoryboardsduringconductofclinicaltrialsinugandaaqualitativestudyinvolvingstakeholders AT ochiengjoseph regulationofcommunityadvisoryboardsduringconductofclinicaltrialsinugandaaqualitativestudyinvolvingstakeholders |